| Key Aspect | Details |
|---|---|
| Breakthrough | Indian scientists develop 'OncoMark', an AI-powered diagnostic model for cancer analysis at the molecular level. |
| Developed by | S N Bose National Centre for Basic Sciences and Ashoka University. |
| Key Innovation | Goes beyond traditional TNM staging, analyzing biological hallmarks driving tumor growth, aggressiveness, and therapy resistance. |
| Features | - Trained on 3.1 million single cells from 14 cancer types. - Uses synthetic pseudo-biopsies for dynamic modeling. - >99% accuracy in internal testing, >96% in independent datasets. |
| Validation | Tested on 20,000 patient samples from 8 major cancer datasets. |
| Applications | - Early detection - Aggressiveness prediction - Drug response analysis - Visual mapping of hallmark activity. |
| Significance | Major step in precision medicine, enabling personalized treatment strategies based on tumor behavior. |
Workflow
Login
Contact Counsellor